Article Information
- Received October 19, 2022
- Revision received March 15, 2023
- Accepted March 21, 2023
- Published online March 27, 2023.
Author Information
- Line I. Christiansen1,
- Bo Holmqvist2,
- Xiaoyu Pan1,
- Kristine Holgersen1,
- Sandy E. H. Lindholm1,
- Nicole L. Henriksen1,
- Douglas G. Burrin3,
- David Ley4,
- Thomas Thymann1,
- Per Torp Sangild1,5,6 and
- Stanislava Pankratova1,7
- 1Comparative Pediatrics and Nutrition, Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, 1870 Frederiksberg, Denmark
- 2ImaGene-iT AB, Medicon Village, 223 81 Lund, Sweden
- 3US Department of Agriculture/Agricultural Research Service, and Department of Pediatrics, Baylor College of Medicine/Texas Children's Hospital, Children’s Nutrition Research Center, Houston, Texas 77030
- 4Department of Clinical Sciences Lund, Pediatrics, Lund University, 221 84 Lund, Sweden
- 5Department of Neonatology, Rigshospitalet, 2100 Copenhagen, Denmark
- 6Department of Pediatrics, Odense University Hospital, 5000 Odense, Denmark
- 7Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark
- Correspondence should be addressed to Stanislava Pankratova at stasya{at}sund.ku.dk.
Author contributions
Author contributions: D.L., T.T., P.T.S., and S.P. designed research; L.I.C., B.H., X.P., K.H., S.E.H.L., N.L.H., D.G.B., D.L., T.T., and S.P. performed research; L.I.C., B.H., X.P., D.G.B., and D.L. analyzed data; L.I.C., D.G.B., P.T.S., and S.P. wrote the paper.
Disclosures
The University of Copenhagen represented by authors K.H., T.T., P.T.S., and S.P., and the company Oak Hill Bio have filed a patent application directed to use of rhIGF-1 for preterm infants. The remaining authors report no conflict of interest.
The University of Copenhagen received funding from Takeda Pharmaceutical Company. This funder was not involved in the study execution, collection, analysis, interpretation of data, the drafting of this article, or the decision to submit it for publication.
Funding
Takeda Pharmaceuticals U.S.A. (TPUSA)
Other Version
- You are viewing the most recent version of this article.
- previous version (March 27, 2023).